Semaglutide 20 mg – GLP-1 Receptor Research Peptide Scientific Background Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1) under investigation for its receptor-agonist activity in in-vitro metabolic and endocrine models. Current studies evaluate binding kinetics, cAMP signalling and downstream pathways relevant to insulinotropic research. Specification Peptide Name: Semaglutide Content: 20 mg lyophilised powder (requires reconstitution) Purity: ≥ 99 % (HPLC / MS certificate available) Manufacturing: ISO 9001:2015 & cGMP-audited facility Intended Use: In-vitro laboratory research only Storage & Handling Prior to reconstitution: store ≤ 8 °C in a dry environment After reconstitution: refrigerate 2 – 8 °C and use within 30 days For long-term preservation: aliquot and freeze at −20 °C Avoid repeated freeze–thaw cycles Compliance Notice Supplied exclusively to qualified professionals for controlled laboratory applications. No dosage or administration guidance is provided. Buyer assumes responsibility for safe handling and regulatory adherence.